HEADER CHAPERONE 25-OCT-05 2ESA TITLE GRP94 N-TERMINAL DOMAIN BOUND TO GELDANAMYCIN: EFFECTS OF MUTANTS 168- TITLE 2 169 KS-AA COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOPLASMIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL DOMAIN OF GRP94 RESIDUES 69-337; COMPND 5 SYNONYM: 94 KDA GLUCOSE-REGULATED PROTEIN, GRP94; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANIS LUPUS FAMILIARIS; SOURCE 3 ORGANISM_COMMON: DOG; SOURCE 4 ORGANISM_TAXID: 9615; SOURCE 5 STRAIN: FAMILIARIS; SOURCE 6 GENE: TRA1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PGEX-NB-GRP94 KEYWDS GRP94 GP96 HSP90 BERGERAT CHAPERONE ENDOPLASMIC RETICULUM KEYWDS 2 GELDANAMYCIN 17-AAG, CHAPERONE EXPDTA X-RAY DIFFRACTION AUTHOR R.M.IMMORMINO,L.E.METZGER IV,D.T.GEWIRTH REVDAT 6 23-AUG-23 2ESA 1 REMARK REVDAT 5 20-OCT-21 2ESA 1 REMARK SEQADV REVDAT 4 02-AUG-17 2ESA 1 SOURCE REVDAT 3 29-FEB-12 2ESA 1 HET HETATM VERSN REVDAT 2 24-FEB-09 2ESA 1 VERSN REVDAT 1 03-OCT-06 2ESA 0 JRNL AUTH R.M.IMMORMINO,L.E.METZGER IV,P.N.REARDON,D.T.GEWIRTH JRNL TITL CRYSTAL STRUCTURE OF GRP94 WITH THE SPECIFIC MUTATION JRNL TITL 2 KS168-169AA; WITH BOUND GELDANAMYCIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.16 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1476847.610 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 78.4 REMARK 3 NUMBER OF REFLECTIONS : 19422 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1961 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1689 REMARK 3 BIN R VALUE (WORKING SET) : 0.2320 REMARK 3 BIN FREE R VALUE : 0.2740 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 200 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1668 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 332 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.77000 REMARK 3 B22 (A**2) : -0.77000 REMARK 3 B33 (A**2) : -1.99000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.19 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 2.200 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 4.080 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 6.280 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 6.470 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.690 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 65.74 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NEW_PEG400.PARAM REMARK 3 PARAMETER FILE 4 : GMYDUN2.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : PEG400.TOP REMARK 3 TOPOLOGY FILE 4 : GMYDUN2.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ESA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 42 REMARK 42 MOLPROBITY STRUCTURE VALIDATION REMARK 42 PROGRAMS : MOLPROBITY (KING, REDUCE, AND PROBE) REMARK 42 AUTHORS : I.W.DAVIS,J.M.WORD REMARK 42 URL : HTTP://KINEMAGE.BIOCHEM.DUKE.EDU/MOLPROBITY/ REMARK 42 AUTHORS : J.S.RICHARDSON,W.B.ARENDALL,D.C.RICHARDSON REMARK 42 REFERENCE : NEW TOOLS AND DATA FOR IMPROVING REMARK 42 : STRUCTURES, USING ALL-ATOM CONTACTS REMARK 42 : METHODS IN ENZYMOLOGY. 2003;374:385-412. REMARK 42 MOLPROBITY OUTPUT SCORES: REMARK 42 ALL-ATOM CLASHSCORE : 9.99 (9.61 B<40) REMARK 42 BAD ROTAMERS : 0.0% 0/176 (TARGET 0-1%) REMARK 42 RAMACHANDRAN OUTLIERS : 0.5% 1/214 (TARGET 0.2%) REMARK 42 RAMACHANDRAN FAVORED : 95.3% 204/214 (TARGET 98.0%) REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-05. REMARK 100 THE DEPOSITION ID IS D_1000035030. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-APR-05 REMARK 200 TEMPERATURE (KELVIN) : 102 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : CU KALPHA REMARK 200 OPTICS : YALE MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19422 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.336 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.7500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.41 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.28800 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.550 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1YT1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 38% PEG 550MME, 30MM MGCL2, 100MM REMARK 280 TRIS, 3.7MM GELDANAMYCIN DELIVERED AS 4UL TO 50UL OF PROTEIN. REMARK 280 STOCK GELDANAMYCIN IS 50MM IN DMSO., PH 8.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.66500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.93500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.19500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.93500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.66500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.19500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS THE ASSUMED BIOLOGICAL UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 65 REMARK 465 SER A 66 REMARK 465 HIS A 67 REMARK 465 MET A 68 REMARK 465 LEU A 69 REMARK 465 ARG A 70 REMARK 465 GLU A 71 REMARK 465 LYS A 72 REMARK 465 SER A 73 REMARK 465 ILE A 166 REMARK 465 ALA A 167 REMARK 465 GLN A 182 REMARK 465 GLU A 183 REMARK 465 ASP A 184 REMARK 465 GLY A 185 REMARK 465 GLN A 186 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 75 CG CD CE NZ REMARK 470 GLU A 130 CG CD OE1 OE2 REMARK 470 LYS A 140 CG CD CE NZ REMARK 470 GLU A 141 CG CD OE1 OE2 REMARK 470 LYS A 161 CG CD CE NZ REMARK 470 GLU A 173 CG CD OE1 OE2 REMARK 470 PHE A 174 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASN A 176 CG OD1 ND2 REMARK 470 LYS A 177 CG CD CE NZ REMARK 470 THR A 179 OG1 CG2 REMARK 470 GLU A 180 CG CD OE1 OE2 REMARK 470 GLU A 190 CG CD OE1 OE2 REMARK 470 LEU A 191 CG CD1 CD2 REMARK 470 PHE A 195 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 273 CG CD OE1 NE2 REMARK 470 PHE A 274 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O1 PG4 A 408 O HOH A 731 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 96 58.65 -146.35 REMARK 500 ASN A 129 102.96 -170.39 REMARK 500 ASN A 129 105.71 -170.39 REMARK 500 GLU A 130 2.78 -68.59 REMARK 500 GLU A 130 37.89 -81.50 REMARK 500 THR A 150 41.25 -107.85 REMARK 500 MET A 178 -71.51 -77.27 REMARK 500 GLU A 180 48.68 -79.53 REMARK 500 SER A 227 -6.05 86.20 REMARK 500 ARG A 243 136.33 -172.40 REMARK 500 TYR A 258 5.54 -67.37 REMARK 500 ASN A 276 42.74 -91.42 REMARK 500 ASN A 276 41.26 -93.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 ONLY FRAGMENTS OF PEG400 (PG4) WERE IDENTIFIED AND IN REMARK 600 MANY CASES SEVERAL ATOMS WERE MISSING DUE TO LACK OF REMARK 600 ELECTRON DENSITY. REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PG4 A 408 REMARK 610 PGE A 409 REMARK 610 PGE A 411 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDM A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE A 409 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE A 411 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QY5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE N-DOMAIN OF THE ER HSP90 CHAPERONE GRP94 REMARK 900 IN COMPLEX WITH THE SPECIFIC LIGAND NECA REMARK 900 RELATED ID: 1U2O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE N-DOMAIN OF GRP94 LACKING THE CHARGED REMARK 900 DOMAIN IN COMPLEX WITH NECA REMARK 900 RELATED ID: 1TBW RELATED DB: PDB REMARK 900 LIGAND INDUCED CONFORMATIONAL SHIFT IN THE N-TERMINAL DOMAIN OF REMARK 900 GRP94, OPEN CONFORMATION REMARK 900 RELATED ID: 1TC0 RELATED DB: PDB REMARK 900 LIGAND INDUCED CONFORMATIONAL SHIFT IN THE N-TERMINAL DOMAIN OF REMARK 900 GRP94, OPEN CONFORMATION COMPLEXED WITH THE PHYSIOLOGICAL PARTNER REMARK 900 ATP REMARK 900 RELATED ID: 1TC6 RELATED DB: PDB REMARK 900 LIGAND INDUCED CONFORMATIONAL SHIFT IN THE N-TERMINAL DOMAIN OF REMARK 900 GRP94, OPEN CONFORMATION ADP-COMPLEX REMARK 900 RELATED ID: 1YT1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE UNLIGANDED FORM OF GRP94 REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE DATABASE RESIDUES 287-327 WERE DELETED REMARK 999 AND REPLACED BY 4 GLYCINES. DBREF 2ESA A 69 286 UNP P41148 ENPL_CANFA 69 286 DBREF 2ESA A 328 337 UNP P41148 ENPL_CANFA 328 337 SEQADV 2ESA GLY A 65 UNP P41148 CLONING ARTIFACT SEQADV 2ESA SER A 66 UNP P41148 CLONING ARTIFACT SEQADV 2ESA HIS A 67 UNP P41148 CLONING ARTIFACT SEQADV 2ESA MET A 68 UNP P41148 CLONING ARTIFACT SEQADV 2ESA ALA A 168 UNP P41148 LYS 168 ENGINEERED MUTATION SEQADV 2ESA ALA A 169 UNP P41148 SER 169 ENGINEERED MUTATION SEQADV 2ESA GLY A 287 UNP P41148 SEE REMARK 999 SEQADV 2ESA GLY A 288 UNP P41148 SEE REMARK 999 SEQADV 2ESA GLY A 289 UNP P41148 SEE REMARK 999 SEQADV 2ESA GLY A 290 UNP P41148 SEE REMARK 999 SEQRES 1 A 236 GLY SER HIS MET LEU ARG GLU LYS SER GLU LYS PHE ALA SEQRES 2 A 236 PHE GLN ALA GLU VAL ASN ARG MET MET LYS LEU ILE ILE SEQRES 3 A 236 ASN SER LEU TYR LYS ASN LYS GLU ILE PHE LEU ARG GLU SEQRES 4 A 236 LEU ILE SER ASN ALA SER ASP ALA LEU ASP LYS ILE ARG SEQRES 5 A 236 LEU ILE SER LEU THR ASP GLU ASN ALA LEU ALA GLY ASN SEQRES 6 A 236 GLU GLU LEU THR VAL LYS ILE LYS CYS ASP LYS GLU LYS SEQRES 7 A 236 ASN LEU LEU HIS VAL THR ASP THR GLY VAL GLY MET THR SEQRES 8 A 236 ARG GLU GLU LEU VAL LYS ASN LEU GLY THR ILE ALA ALA SEQRES 9 A 236 ALA GLY THR SER GLU PHE LEU ASN LYS MET THR GLU ALA SEQRES 10 A 236 GLN GLU ASP GLY GLN SER THR SER GLU LEU ILE GLY GLN SEQRES 11 A 236 PHE GLY VAL GLY PHE TYR SER ALA PHE LEU VAL ALA ASP SEQRES 12 A 236 LYS VAL ILE VAL THR SER LYS HIS ASN ASN ASP THR GLN SEQRES 13 A 236 HIS ILE TRP GLU SER ASP SER ASN GLU PHE SER VAL ILE SEQRES 14 A 236 ALA ASP PRO ARG GLY ASN THR LEU GLY ARG GLY THR THR SEQRES 15 A 236 ILE THR LEU VAL LEU LYS GLU GLU ALA SER ASP TYR LEU SEQRES 16 A 236 GLU LEU ASP THR ILE LYS ASN LEU VAL LYS LYS TYR SER SEQRES 17 A 236 GLN PHE ILE ASN PHE PRO ILE TYR VAL TRP SER SER LYS SEQRES 18 A 236 THR GLY GLY GLY GLY LYS THR VAL TRP ASP TRP GLU LEU SEQRES 19 A 236 MET ASN HET GDM A 401 40 HET PG4 A 408 10 HET PGE A 409 7 HET PGE A 411 7 HETNAM GDM GELDANAMYCIN HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM PGE TRIETHYLENE GLYCOL FORMUL 2 GDM C29 H40 N2 O9 FORMUL 3 PG4 C8 H18 O5 FORMUL 4 PGE 2(C6 H14 O4) FORMUL 6 HOH *332(H2 O) HELIX 1 1 GLN A 79 SER A 92 1 14 HELIX 2 2 LEU A 93 LYS A 97 5 5 HELIX 3 3 GLU A 98 ASP A 122 1 25 HELIX 4 4 GLU A 123 ALA A 127 5 5 HELIX 5 5 THR A 155 LEU A 163 1 9 HELIX 6 6 ALA A 169 THR A 179 1 11 HELIX 7 7 SER A 187 PHE A 195 1 9 HELIX 8 8 VAL A 197 LEU A 204 5 8 HELIX 9 9 GLU A 253 LEU A 259 5 7 HELIX 10 10 GLU A 260 SER A 272 1 13 SHEET 1 A 9 PHE A 76 ALA A 77 0 SHEET 2 A 9 GLU A 229 ALA A 234 -1 O PHE A 230 N PHE A 76 SHEET 3 A 9 HIS A 221 SER A 225 -1 N ILE A 222 O ILE A 233 SHEET 4 A 9 ALA A 206 LYS A 214 -1 N VAL A 211 O TRP A 223 SHEET 5 A 9 GLY A 244 LEU A 251 -1 O THR A 248 N ILE A 210 SHEET 6 A 9 LEU A 144 ASP A 149 -1 N LEU A 145 O LEU A 249 SHEET 7 A 9 VAL A 134 ASP A 139 -1 N LYS A 135 O THR A 148 SHEET 8 A 9 ILE A 279 GLY A 288 1 O TYR A 280 N VAL A 134 SHEET 9 A 9 LYS A 328 LEU A 335 -1 O VAL A 330 N LYS A 285 SITE 1 AC1 20 ASN A 107 ALA A 108 ASP A 110 ALA A 111 SITE 2 AC1 20 LYS A 114 ASP A 149 ASN A 162 LEU A 163 SITE 3 AC1 20 GLY A 196 VAL A 197 GLY A 198 PHE A 199 SITE 4 AC1 20 THR A 245 HOH A 412 HOH A 413 HOH A 415 SITE 5 AC1 20 HOH A 432 HOH A 439 HOH A 526 HOH A 682 SITE 1 AC2 11 THR A 212 ARG A 237 THR A 240 THR A 248 SITE 2 AC2 11 HOH A 449 HOH A 453 HOH A 515 HOH A 631 SITE 3 AC2 11 HOH A 713 HOH A 718 HOH A 731 SITE 1 AC3 7 LYS A 137 HIS A 146 HOH A 427 HOH A 598 SITE 2 AC3 7 HOH A 602 HOH A 632 HOH A 718 SITE 1 AC4 4 ASN A 129 ASN A 239 HOH A 654 HOH A 710 CRYST1 47.330 66.390 75.870 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021128 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015063 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013180 0.00000